These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1983413

  • 1. Long-term treatment for gastric and duodenal ulcer.
    Di Mario F, Battaglia G, Pasqualetti P, Vio A, Gottardello L, Grassi SA.
    Ital J Gastroenterol; 1990; 22 Suppl 2():24-8. PubMed ID: 1983413
    [Abstract] [Full Text] [Related]

  • 2. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD.
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [Abstract] [Full Text] [Related]

  • 3. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection.
    Freston JW.
    Am J Gastroenterol; 1987 Dec; 82(12):1242-9. PubMed ID: 2891294
    [Abstract] [Full Text] [Related]

  • 4. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E.
    Wien Med Wochenschr; 1983 Dec; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract] [Full Text] [Related]

  • 5. Intermittent treatment of duodenal ulcer for long term medical management.
    Bardhan KD.
    Postgrad Med J; 1988 Dec; 64 Suppl 1():40-6. PubMed ID: 2901744
    [Abstract] [Full Text] [Related]

  • 6. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs.
    Di Mario F, Gottardello L, Germanà B, Dotto P, Grassi SA, Vianello F, Battaglia G, Leandro G, Burra P, Salvagnini M.
    Ital J Gastroenterol; 1992 Dec; 24(3):122-5. PubMed ID: 1348650
    [Abstract] [Full Text] [Related]

  • 7. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ, Fennerty B, Fagan TC.
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [Abstract] [Full Text] [Related]

  • 8. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy.
    Lima M, Holdcroft C.
    Nurse Pract; 1989 Feb; 14(2):41-2. PubMed ID: 2564655
    [Abstract] [Full Text] [Related]

  • 9. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Feb; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [Abstract] [Full Text] [Related]

  • 10. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M, Dezi A, Ferrario F, Capurso I.
    Arch Intern Med; 1996 Nov 11; 156(20):2321-32. PubMed ID: 8911239
    [Abstract] [Full Text] [Related]

  • 11. [Medical therapy of peptic ulcer: problems and prospects].
    Trabucchi E, Foschi D, Belloli P, Montorsi F, Marchetti V, Mariscotti C, Diamantini S.
    Minerva Dietol Gastroenterol; 1989 Nov 11; 35(1):1-6. PubMed ID: 2566959
    [Abstract] [Full Text] [Related]

  • 12. Review of peptic ulcer maintenance trials.
    Robinson M.
    Am J Med; 1984 Nov 19; 77(5B):23-9. PubMed ID: 6095657
    [Abstract] [Full Text] [Related]

  • 13. Giant gastric ulcer: its natural history and outcome in the H2RA era.
    Raju GS, Bardhan KD, Royston C, Beresford J.
    Am J Gastroenterol; 1999 Dec 19; 94(12):3478-86. PubMed ID: 10606307
    [Abstract] [Full Text] [Related]

  • 14. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T, Hirata W, Higichi S.
    Int J Clin Pharmacol Res; 2002 Dec 19; 22(2):29-35. PubMed ID: 12503773
    [Abstract] [Full Text] [Related]

  • 15. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S, Clausi GG, Farinelli M, Santucci L, Farroni F, Pelli MA, Morelli A.
    Am J Gastroenterol; 1988 Dec 19; 83(12):1371-5. PubMed ID: 2904218
    [Abstract] [Full Text] [Related]

  • 16. [Nizatidine].
    Romero M, Franzosi MG.
    Medicina (Firenze); 1989 Dec 19; 9(1):93-6. PubMed ID: 2567957
    [Abstract] [Full Text] [Related]

  • 17. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Dec 19; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 18. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T, Lemaire M, Agostini H.
    Eur J Gastroenterol Hepatol; 1995 Jul 19; 7(7):661-5. PubMed ID: 8590162
    [Abstract] [Full Text] [Related]

  • 19. Famotidine in the USA: a review of efficacy studies.
    Gitnick G.
    J Int Med Res; 1989 Jul 19; 17 Suppl 1():17A-24A. PubMed ID: 2566539
    [Abstract] [Full Text] [Related]

  • 20. The histological maturity of regenerating mucosa of healed duodenal ulcer and ulcer recurrence after treatment with H2-antagonist.
    Pan S, Liao CH.
    Am J Gastroenterol; 1990 Aug 19; 85(8):949-52. PubMed ID: 1973870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.